• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动静脉内瘘穿刺部位过度出血预示慢性血液透析患者的长期全因死亡率。

Excessive Access Cannulation Site Bleeding Predicts Long-Term All-Cause Mortality in Chronic Hemodialysis Patients.

作者信息

Tsai Wan-Chuan, Chen Hung-Yuan, Lin Chi-Lin, Huang Shu-Chen, Hsu Shih-Ping, Pai Mei-Fen, Peng Yu-Sen, Chiu Yen-Ling

机构信息

Division of Nephrology, Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei City, Taiwan.

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Ther Apher Dial. 2015 Oct;19(5):486-90. doi: 10.1111/1744-9987.12304. Epub 2015 May 5.

DOI:10.1111/1744-9987.12304
PMID:25944488
Abstract

Our group has previously reported that excessive vascular access bleeding during dialysis treatment in stable hemodialysis (HD) patients was associated with anemia and may indicate poorer health. The association between excessive blood loss from access cannulation site and clinical outcomes was unknown. We hypothesized that excessive access bleeding may have an impact on all-cause and cardiovascular (CV) mortality in this population. We prospectively conducted an observational, longitudinal study of 360 HD patients. Excessive access bleeding was defined as at least an occurrence of blood loss greater than 4 mL per HD session during a study period of one month. During a median follow-up of 83 months, all-cause mortality and CV mortality were registered. Outcomes were analyzed by Kaplan-Meier and Cox proportional hazards regression analyses. A total of 118 (32.8%) participants died and 54 of these were from CV death. Using a multivariate Cox proportional hazards regression, access bleeding was found to be an independent predictor of all-cause mortality (HR 1.67, 95% CI 0.96-2.91, P = 0.070) but not for CV death (HR 1.53, 95% CI 0.88-2.68, P = 0.135). Our study identified that excessive access cannulation site bleeding could be a novel marker for increased risk of death in HD patients.

摘要

我们的研究小组之前曾报告,稳定的血液透析(HD)患者在透析治疗期间血管通路过度出血与贫血有关,可能预示健康状况较差。血管通路插管部位失血过多与临床结局之间的关联尚不清楚。我们推测,过度的血管通路出血可能会影响该人群的全因死亡率和心血管(CV)死亡率。我们对360例HD患者进行了一项前瞻性观察性纵向研究。过度的血管通路出血定义为在为期一个月的研究期间,每次HD治疗至少发生一次失血量大于4毫升的情况。在中位随访83个月期间,记录了全因死亡率和CV死亡率。通过Kaplan-Meier和Cox比例风险回归分析对结局进行分析。共有118名(32.8%)参与者死亡,其中54例死于CV死亡。使用多变量Cox比例风险回归分析,发现血管通路出血是全因死亡率的独立预测因素(HR 1.67,95% CI 0.96-2.91,P = 0.070),但不是CV死亡的独立预测因素(HR 1.53,95% CI 0.88-2.68,P = 0.135)。我们的研究发现,血管通路插管部位过度出血可能是HD患者死亡风险增加的一个新标志。

相似文献

1
Excessive Access Cannulation Site Bleeding Predicts Long-Term All-Cause Mortality in Chronic Hemodialysis Patients.动静脉内瘘穿刺部位过度出血预示慢性血液透析患者的长期全因死亡率。
Ther Apher Dial. 2015 Oct;19(5):486-90. doi: 10.1111/1744-9987.12304. Epub 2015 May 5.
2
Increased blood loss from access cannulation site during hemodialysis is associated with anemia and arteriovenous graft use.血液透析期间动静脉内瘘穿刺部位失血增加与贫血及动静脉移植物的使用有关。
Ther Apher Dial. 2014 Feb;18(1):51-6. doi: 10.1111/1744-9987.12026. Epub 2013 Mar 28.
3
Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.脑利钠肽在血液透析患者传统和非传统危险因素之间的作用:对两年随访中心血管死亡率的分析。
Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8.
4
Ankle-brachial index and cardiovascular mortality in nondiabetic hemodialysis patients.非糖尿病血液透析患者的踝臂指数与心血管死亡率
Ther Apher Dial. 2013 Aug;17(4):373-7. doi: 10.1111/1744-9987.12081.
5
Left ventricular mass index and aortic arch calcification score are independent mortality predictors of maintenance hemodialysis patients.左心室质量指数和主动脉弓钙化评分是维持性血液透析患者独立的死亡预测指标。
Hemodial Int. 2012 Oct;16(4):504-11. doi: 10.1111/j.1542-4758.2012.00700.x. Epub 2012 Apr 22.
6
Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.骨保护素与患有心血管疾病的血液透析患者的死亡率
Clin Nephrol. 2013 Sep;80(3):161-7. doi: 10.5414/CN107803.
7
A comparison of medium-term survival between peritoneal dialysis and haemodialysis in accordance with the initial vascular access.根据初始血管通路比较腹膜透析和血液透析的中期生存率。
Nefrologia. 2013;33(5):629-39. doi: 10.3265/Nefrologia.pre2013.May.12048.
8
Fetuin A/nutritional status predicts cardiovascular outcomes and survival in hemodialysis patients.胎球蛋白A/营养状况可预测血液透析患者的心血管结局和生存率。
Am J Nephrol. 2014;40(3):233-41. doi: 10.1159/000366523. Epub 2014 Oct 11.
9
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.血液透析中的慢性炎症与死亡率:不同肾脏替代疗法的影响。RISCAVID研究结果
Nephrol Dial Transplant. 2008 Jul;23(7):2337-43. doi: 10.1093/ndt/gfm951. Epub 2008 Feb 27.
10
Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis.踝臂血压指数而非肱踝脉搏波速度是维持性血液透析患者系统性动脉粥样硬化发病率和死亡率的强有力预测指标。
Atherosclerosis. 2011 Dec;219(2):643-7. doi: 10.1016/j.atherosclerosis.2011.09.037. Epub 2011 Oct 1.

引用本文的文献

1
Vascular access cannulation and haemostasis: a national observational study of French practices.血管通路插管与止血:一项关于法国实践的全国性观察研究。
Clin Kidney J. 2020 Oct 2;14(4):1261-1268. doi: 10.1093/ckj/sfaa098. eCollection 2021 Apr.
2
Renal Association Clinical Practice Guideline on Haemodialysis.英国肾脏病学会血液透析临床实践指南
BMC Nephrol. 2019 Oct 17;20(1):379. doi: 10.1186/s12882-019-1527-3.